The nanocrystalline technology platform provides an excellent opportunity for the delivery of hydrophobic drugs. Nanocrystal technology has been widely studied and is well-suited for further exploration in the field of hydrophobic drug delivery. CD Formulation can provide our clients with nanocrystalline technology services for nanocrystals depending on our advanced nanocrystalline technology platform.
Nanocrystals are solid particles characterized by their small size, typically less than 1 μm in diameter, and possess crystalline properties. These particles consist entirely of the active drug or payload, eliminating the need for a carrier substance. The utilization of nanocrystalline technology enhances the solubility of hydrophobic drugs by increasing the surface area to volume ratio due to their nanoscale dimensions, thereby improving the dissolution rate. This technology is appealing for its simplicity in formulation, consistent composition, and cost-effectiveness. Additionally, nanocrystalline technology has the potential to address various challenges encountered in drug development, such as enhancing the bioavailability of poorly soluble drugs by converting them into nanocrystals, which can lead to improved dissolution rates and saturation solubility.
Fig.1 Nanocrystallization of poorly soluble drugs improves physicochemical stability and drug bioavailability. (Maria Jarvis, et al. 2019)
Because of its unique advantages, such as 100% effective load, nanocrystalline technology has broad applications in oral, parenteral, ocular, skin, lung and targeted drug delivery.
Due to the small particle size of nanocrystals, it can enhance uniform distribution in the gastrointestinal tract and reduce local long-term concentration. Nanocrystals are also well tolerated in the mucosa due to minimal irritation to the stomach.
Nanocrystals can improve the effectiveness of drugs through various parenteral routes such as intravenous, subcutaneous, intramuscular, intraarticular, and intraperitoneal. Due to the small particle size, nanocrystals can be administered via intravenous injection with reduced doses, rapid onset, and maximum bioavailability.
The deposition of drugs in the lungs can be controlled by the size distribution of nanocrystals. Aqueous nanosuspensions are prepared by ultrasonic methods for drug delivery to the lungs. Nanocrystals tend to adhere to the mucosal surface and prolong the residence time, thereby increasing the absorption of the drug. At the same time, the distribution of nanocrystals on the bronchial surface is more uniform.
Nanocrystals have advantages such as long residence time, which is required for the effective treatment of most ocular diseases. It also provides low tension, and its performance depends on the intrinsic solubility of the drug in tears. Therefore, the intrinsic dissolution rate of the drug in tears determines its bioavailability and ocular release.
Targeted drug delivery allows the drug to accumulate in a specific targeted area for treatment. Nanocrystals used for targeted drug delivery have specific interactions with receptors in the target tissue. Targeting ligands and other functional groups can also be added to the surface of nanocrystals. In this way, nanocrystals can be integrated into various matrix structures and targeted to specific tissues/organs to exert their effects.
Fig.2 Different applications of nanocrystalline technology. (CD Formulation)
Relying on our advanced design concept and nanocrystalline technology platform, CD Formulation focuses on the development and application of nanocrystal preparation and characterization technologies. We are able to design and prepare nanocrystals that meet the quality requirements of our customers based on their different needs.
Nanocrystals are usually produced by two methods, namely top-down and bottom-up.
Top-Down Methods: Top-down methods include methods such as media milling (pearl milling) and high-pressure homogenization (HPH). In these methods, large-sized particles are broken down into smaller sizes.
Bottom-Up Methods: The bottom-up approach to growing nanocrystals from solutions involves two critical steps: nucleation and crystal growth.
Properties such as crystallinity, size, shape, surface charge, and the type of stabilizers or polymer coatings used during formulation can affect the therapeutic efficacy of nanocrystals. Therefore, relying on our advanced instrumentation, we have built a nanocrystal characterization technology platform to monitor the properties of nanocrystals in real time to ensure that our customized nanocrystals meet the expected quality requirements.
With the help of our nanocrystalline technology, we can provide customers with personalized nanocrystal development and customization services to meet their specific needs. With a deep understanding of the unique properties of nanocrystals and their uses, we are committed to creating customized nanocrystal solutions to improve the clinical effectiveness and bioavailability of different pharmaceutical and biotech products.
Technology: Nanocrystal production technology platform based on metal phenolic networks (MPNs)
Journal: AAPS PharmSciTech
IF: 3.3
Published: 2022
Results:
The authors report a nanocrystal production technology platform based on metal phenolic networks (MPNs). MPN-encapsulated nanocrystalline particles (MPN-NPs) were prepared by antisolvent precipitation using tannic acid and FeIII or AlIII as coupling agents and characterized by dynamic light scattering, transmission electron microscopy, UV-visible spectrophotometry, Fourier transform infrared spectroscopy, and X-ray powder diffraction. The authors focused on the in vitro release, cytotoxicity, and stability of MPN-NPs loaded with paclitaxel. The applicability of MPN as a nanocrystal stabilizer for other classical hydrophobic drugs was also investigated. The results suggest that MPNs may be a promising nanocrystal production platform to address the low solubility challenges associated with hydrophobic drugs.
Fig.3 Preparation of MPN-encapsulated nanocrystalline particles (MPN-NPs). (Feifei Huang, et al.2022)
Nanocrystals have great potential in the field of drug delivery and therapeutics. With our nanocrystal technology platform, CD Formulation reformulates poorly soluble drugs into new nanocrystals for clinical use, providing pharmaceutical companies with a clear competitive advantage. If you are interested in our nanocrystalline technology service, please kindly contact us.
References